Wanjia Group Holdings Limited (HKG:0401)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.202
+0.010 (5.21%)
Apr 29, 2026, 4:08 PM HKT
134.88%
Market Cap 227.98M
Revenue (ttm) 163.70M
Net Income (ttm) -8.58M
Shares Out 1.13B
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,035,000
Average Volume 2,368,363
Open 0.195
Previous Close 0.192
Day's Range 0.195 - 0.209
52-Week Range 0.051 - 0.209
Beta 1.12
RSI 70.97
Earnings Date Jun 18, 2026

About Wanjia Group Holdings

Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company offers hemodialysis treatment and consultancy services. It sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloo... [Read more]

Sector Healthcare
Founded 2004
Employees 177
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0401
Full Company Profile

Financial Performance

In fiscal year 2025, Wanjia Group Holdings's revenue was 161.69 million, a decrease of -10.71% compared to the previous year's 181.09 million. Losses were -6.62 million, -83.45% less than in 2024.

Financial Statements

News

There is no news available yet.